NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
TSX-V:NLH - TSX Venture Exchange - CA66980G1090 - Common Stock - Currency: CAD
We assign a fundamental rating of 3 out of 10 to NLH. NLH was compared to 15 industry peers in the Health Care Providers & Services industry. NLH has an average financial health and profitability rating. NLH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
NLH had positive earnings in the past year.
In the past year NLH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
Each year in the past 5 years NLH had a positive operating cash flow.
1.2 Ratios
NLH has a Return On Assets of 3.57%. This is in the better half of the industry: NLH outperforms 73.33% of its industry peers.
NLH has a better Return On Equity (4.54%) than 66.67% of its industry peers.
NLH has a Return On Invested Capital of 3.00%. This is in the better half of the industry: NLH outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.57% | ||
| ROE | 4.54% | ||
| ROIC | 3% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 3.13%, NLH perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
In the last couple of years the Profit Margin of NLH has declined.
NLH's Operating Margin of 2.85% is in line compared to the rest of the industry. NLH outperforms 60.00% of its industry peers.
With a Gross Margin value of 38.64%, NLH perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
In the last couple of years the Gross Margin of NLH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.85% | ||
| PM (TTM) | 3.13% | ||
| GM | 38.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NLH is destroying value.
The number of shares outstanding for NLH has been increased compared to 1 year ago.
NLH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NLH has a worse debt to assets ratio.
2.2 Solvency
NLH has an Altman-Z score of 2.87. This is not the best score and indicates that NLH is in the grey zone with still only limited risk for bankruptcy at the moment.
NLH has a better Altman-Z score (2.87) than 80.00% of its industry peers.
NLH has a debt to FCF ratio of 2.82. This is a good value and a sign of high solvency as NLH would need 2.82 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.82, NLH belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
NLH has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.05, NLH belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 2.82 | ||
| Altman-Z | 2.87 |
ROIC/WACC0.38
WACC7.82%
2.3 Liquidity
NLH has a Current Ratio of 0.82. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
NLH's Current ratio of 0.82 is in line compared to the rest of the industry. NLH outperforms 46.67% of its industry peers.
NLH has a Quick Ratio of 0.82. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
NLH has a Quick ratio (0.82) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 382.35% over the past year.
The earnings per share for NLH have been decreasing by -11.19% on average. This is quite bad
NLH shows a small growth in Revenue. In the last year, the Revenue has grown by 0.81%.
NLH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.16% yearly.
EPS 1Y (TTM)382.35%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-116.67%
Revenue 1Y (TTM)0.81%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%10.33%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 22.50 indicates a rather expensive valuation of NLH.
Compared to the rest of the industry, the Price/Earnings ratio of NLH indicates a somewhat cheap valuation: NLH is cheaper than 73.33% of the companies listed in the same industry.
NLH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.54.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NLH is valued a bit cheaper than 73.33% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NLH indicates a somewhat cheap valuation: NLH is cheaper than 73.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.06 | ||
| EV/EBITDA | 11.79 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NLH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:NLH (8/7/2025, 7:00:00 PM)
0.225
+0.01 (+2.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.98%
Ins Owner ChangeN/A
Market Cap19.64M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.5 | ||
| Fwd PE | N/A | ||
| P/S | 0.54 | ||
| P/FCF | 12.06 | ||
| P/OCF | 11.81 | ||
| P/B | 0.79 | ||
| P/tB | 20.78 | ||
| EV/EBITDA | 11.79 |
EPS(TTM)0.01
EY4.44%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY8.29%
OCF(TTM)0.02
OCFY8.47%
SpS0.42
BVpS0.29
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.57% | ||
| ROE | 4.54% | ||
| ROCE | 3.95% | ||
| ROIC | 3% | ||
| ROICexc | 3.23% | ||
| ROICexgc | 269.04% | ||
| OM | 2.85% | ||
| PM (TTM) | 3.13% | ||
| GM | 38.64% | ||
| FCFM | 4.49% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
F-Score6
Asset Turnover1.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 2.82 | ||
| Debt/EBITDA | 0.62 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 6.07 | ||
| Cash Conversion | 87.57% | ||
| Profit Quality | 143.33% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 2.87 |
F-Score6
WACC7.82%
ROIC/WACC0.38
Cap/Depr(3y)4.23%
Cap/Depr(5y)2.79%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)382.35%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-116.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.81%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%10.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.06%
FCF growth 3Y-14.49%
FCF growth 5Y17.9%
OCF growth 1Y27.88%
OCF growth 3Y-13.97%
OCF growth 5Y17.73%